
We run cohorts in London twice a year, with between 50 and 100 prospective founders taking part. In addition to our Core programme, in London we bring together Graduate and web3 specialist cohorts.
Our London companies include Tractable who recently raised a US$60M Series D round, and accuRx, who played a critical role in the UK’s vaccine roll-out.
We’ve seen several successful exits from our London cohorts, including Magic Pony Technology who were acquired for a reported US$150M.